Three investment ideas for a diversified portfolio

A diversified portfolio is an investor’s best friend when aiming for consistent returns. Too much of one type of investment, or omitting another sector entirely, could see them overexposed should the unexpected happen. With 2020 – and potentially 2021 – still able to throw investors some curveballs, here we have collated three investment ideas thatContinue reading “Three investment ideas for a diversified portfolio”

S&P Global in talks to pull off the biggest deal of 2020

Salesforce’s talks of a deal with workplace communications firm Slack dominated headlines late last week, but an even bigger deal was reported over the weekend. Per The WSJ, financial information firm S&P Global is in advanced talks to buy fellow data giant IHS Markit for $44bn. If that price stands, the deal would be theContinue reading “S&P Global in talks to pull off the biggest deal of 2020”

Tesla nears $500bn market cap as markets rally on Trump power transfer

European markets have maintained yesterday’s momentum with news of easing lockdowns in the UK and France adding to the optimism.  The FTSE is up 0.5%, the Dax up 0.4% and the Dow Jones leading way in the US futures market up 1%. Markets around the world rose on Monday and overnight as further vaccine news,Continue reading “Tesla nears $500bn market cap as markets rally on Trump power transfer”

US Treasury and Federal Reserve clash over pandemic response

European markets have opened marginally more positive this morning, but today’s upcoming session has been clouded as officials in Washington clash over the pandemic response. Treasury Secretary Steven Mnuchin and Federal Reserve Chairman Jerome Powell found themselves in disagreement over several emergency lending programs that were started to support businesses during the Covid-19 pandemic. MnuchinContinue reading “US Treasury and Federal Reserve clash over pandemic response”

Second effective vaccine fuels rally, Tesla joins S&P

Dominating headlines yesterday was the news that Moderna’s Covid-19 vaccine has proven 94.5% effective in a late-stage trial, a week after Pfizer reported similar results in its own trial. More data is expected from the study later this month, and Moderna said that it plans to ask health authorities to clear the vaccine by earlyContinue reading “Second effective vaccine fuels rally, Tesla joins S&P”

Create your website with WordPress.com
Get started